- Home
- HRMY vs OSW Comparison
HRMY vs OSW Comparison
Compare HRMY & OSW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HRMY | OSW |
|---|---|---|
| Founded | 2017 | 2017 |
| Country | United States | Bahamas |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Hotels/Resorts |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.2B |
| IPO Year | 2020 | N/A |
Fundamental Metrics
Financial Performance| Metric | HRMY | OSW |
|---|---|---|
| Price | $38.13 | $21.36 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 3 |
| Target Price | ★ $51.33 | $24.33 |
| AVG Volume (30 Days) | ★ 695.1K | 538.9K |
| Earning Date | 11-04-2025 | 10-29-2025 |
| Dividend Yield | N/A | ★ 0.94% |
| EPS Growth | ★ 50.44 | 40.79 |
| EPS | ★ 3.17 | 0.70 |
| Revenue | $825,944,000.00 | ★ $936,080,000.00 |
| Revenue This Year | $23.11 | $8.68 |
| Revenue Next Year | $16.15 | $8.04 |
| P/E Ratio | ★ $12.04 | $30.54 |
| Revenue Growth | ★ 21.13 | 7.27 |
| 52 Week Low | $25.52 | $14.21 |
| 52 Week High | $40.93 | $23.49 |
Technical Indicators
Market Signals| Indicator | HRMY | OSW |
|---|---|---|
| Relative Strength Index (RSI) | 57.61 | 56.75 |
| Support Level | $37.12 | $21.15 |
| Resistance Level | $39.60 | $22.04 |
| Average True Range (ATR) | 1.21 | 0.57 |
| MACD | -0.34 | 0.15 |
| Stochastic Oscillator | 28.27 | 75.46 |
Price Performance
Historical ComparisonAbout HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant) is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and is used for the treatment of cataplexy in adult patients with narcolepsy. The other drug candidates in its pipeline are Pitolisant, HBS-102 (MCHR1 antagonist), BP1.15205 (orexin-2 receptor agonist), ZYN002 (cannabidiol gel), EPX-100 (clemizole hydrochloride), and EPX-200 (lorcaserin), among others.
About OSW OneSpaWorld Holdings Limited
OneSpaWorld Holdings Ltd is an operator of health and wellness centers onboard cruise ships and an operator of health and wellness centers at destination resorts all over the world. It offers a suite of premium health, fitness, beauty, and wellness services and products. The services provided by the company include body, salon, and skin care services and products, fitness classes and personal fitness training and pain management, detoxifying programs, and comprehensive body composition analyses among others. The company has only one single segment of Maritime and Destination Resorts.